ACT-GLOBAL Platform Trial for Stroke

Conditions: Stroke Interventions: Drug: Standard-dose intravenous tenecteplase; Drug: Low-dose intravenous tenecteplase; Other: No intravenous tenecteplase; Other: Conservative Blood Pressure Control; Other: Moderate Blood Pressure Control; Other: Intensive Blood Pressure Control; Other: Placebo; Drug: NoNO-42 Sponsors: The George Institute; University of Calgary; Berry Consultants Not yet recruiting

https://clinicaltrials.gov/study/NCT06352632

Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials

More News: Research | Stroke